alexa Changing Hepatitis C Genotypes In South Africa Including A Closer Look At Genotype 5a
ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th World Congress on Virology
October 06-08, 2014 Hilton San Antonio Airport, TX, USA

Prabdial-Sing, N, Blackard, J, Manamela, J, Hlanzi, M, Thaver, J, Smuts, H, Vermeulen, M, Mahomed, A, Abuelhassan, W, Suchard, M, Puren, A.J. and Bowyer, SM
ScientificTracks Abstracts: J Antivir Antiretrovir
DOI: 10.4172/1948-5964.S1.020
Abstract
Around 1 million South Africans are infected with Hepatitis C virus. Most individuals remain undiagnosed until symptoms occur and, therefore, usually present with late stage liver disease. The standard of care (SOC) for treating hepatitis C in South Africa is combination therapy with pegylated interferon and ribavirin. However, not all South Africans have access to (or are able to benefit from) therapy due to high costs, poor adherence, adverse side effects and advanced stage of disease. HCV genotypes and/or mutations in the core/ non-structural regions have been associated with response to therapy and/or disease progression. Although the major genotype in South Africa is genotype 5a, studies using clinical cohorts confirm that other local genotype frequencies are increasing due to population migration and travel. This retrospective study describes (1) changing genotype frequencies within a South African high-risk clinical patient group as well as a low risk (asymptomatic) cohort of blood donors bled between the years 2008-2012and (2) molecularly characterize the core and NS5B regions of all pre-treatment samples. Methods: Sera samples from hospitals around South Africa (N=865) and from the South African Blood Services (SANBS, N=206) were analyzed quantitatively by real-time PCR and genotyped using the Versant LiPA assay. Mutational analyses were performed for selected genotype 5a samples as follows: Thirty-one samples were sequenced directly in the core region (patients N=21 and blood donors N=10) while retrospective data from 43, previously sequenced, patient samples was analyzed in the NS5B region. Mutations were identified using Mega 6.0. Sequences were compared to GenBank references for amino acids 1-318 of core and E1 and amino acids 2661-2728 of NS5B. Sequence variability was examined for known CD4+ and CD8+ T-cell epitopes and their predicted binding to HLA types known to be prevalent in the South African population determined using IEDB. Results: Genotype 5a (35.83%) was the major genotype in the patient cohort whilst genotype 1 (33.98%), was found to predominate in the blood donors. An increase in genotypes 3 and 4 was noted over the 5 year study period in both cohorts. The core: R70Q mutation (associated with poor response to pegylated interferon and ribavirin therapy in genotype 1b patients and progression to HCC) was identified in 20/21 patient samples with genotype 5a and 9 of 10 genotype 5a blood donor samples. The NS5B:S282T mutation (associated with resistance) was not seen at baseline in any of the genotype 5a samples studied. Six of the 9 known HLA-A02 restricted epitope sequences showed high-intermediate cross-reactivity (binding scores of <300 IC50nM) to two of the most common alleles present in the South African population. No known CD8+ T-cell epitopes were mapped to the sequenced NS5B region. Discussion: The study highlights the need for ongoing genotyping surveillance of HCV in South Africa to monitor changing frequencies and their impact on health care costs and burden of disease. It also broadens our knowledge and provides new insight into the diversity of HCV in pre-treatment samples belonging to the poorly studied genotype 5a which predominates in South Africa.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords